“DELIVER has delivered”! Congratulations to @scottdsolomon & team for the positive results of the DELIVER trial in patients with HFpEF/HFmrEF, including HFimpEF! Stay tuned for the multitude of simultaneous publications during #ESCCongress https://t.co/FRxLORBGbN @TheresaMcDonag3
Delighted to share our recent work from the #PCHF_VAD registry published in the Eur J Heart Fail depicting the evolving landscape of #LVAD recipients in Europe, with ⬆️ survival and ⬇️ adverse events in the most recent implantation era! Kudos @NinaJakus ⭐️ https://t.co/12OdezISlP
#ESCCongress Advances in #LVAD:
🌟Could fully internalized systems be available in the next 2 years? 🤓
🌟Smart pumping in the future: Unloading of the LV and provision of cardiac output should follow physiological needs of the patient! 🚴♀️⛷🏌️♀️🧗
#ESCCongress Difficult decisions in advanced #HF
💫#FinnGustafsson: the advanced #HF community should continue providing high quality data proving the efficacy and safety of #LVADs
The #PCHF_VAD registry by the #PCHF_HFA participants continues to enroll, now >600 LVAD carries!
#ESCCongress Hot line session, APAF CRT trial:
⚡️survival advantage of the pace and ablate strategy (AV node ablation+BiV pacing) in patients with symptomatic permanent #AFib & narrow QRS
⚡️no interaction with LVEF (LVEF<35% or >35%)
@ESC_Journals#EHJ
https://t.co/lZ39Y4SPbs
Proud to share our research @IPlaninc: synchrotron-based X‑ray phase contrast imaging in post-MI #HeartFailure-fascinating images of myocardial remodeling on whole organ, tissue, vascular & cellular level using a single, non-destructive 3D imaging modality https://t.co/PiPjy77wRf